South Korea Psoriasis Treatment Market: Segmented By Drug Class (Tumour Necrosis Factor [TNF] Inhibitors, Interleukin-Inhibitors, Corticosteroids, Vitamin D Analogues), and By Treatment Type (Topical, Systemic, Biologics)- Growth, Trends and Forecasts (2019 2028)
Report Overview The South Korea psoriasis treatment market size stood at around USD 27.71 million in 2019 and is proj... Read More
-
Dec 2022
-
Pages: 200
- Get FREE Sample
South Korea Atopic Dermatitis Treatment Market: Segmented By Drug Class (Corticosteroids, Emollients/Moisturizers, IL-4 and PDE4 Inhibitors, Calcineurin Inhibitors, Antibiotics, Other Drugs), and By Route of Administration (Topical, Oral, Injectable)- Growth, Trends and Forecasts (2019 2028)
Report Overview The South Korea atopic dermatitis treatment market size stood at around USD 39.60 million in 2020 and... Read More
-
Dec 2022
-
Pages: 200
- Get FREE Sample
South Korea Anti- Aging Therapeutics Market: Segmented By Drug Class (Serums and Supplements, Antioxidants And Enzymes, Stem Cells, Medication), By Product Type (UV Absorbers, Anti-Wrinkle Products, Anti-Stretch Marks Products, Natural Products and Others), and By Devices (Anti Cellulite Treatment Devices, Microderm Abrasion Devices, Laser Aesthetic Devices, and Radiofrequency Devices)- Growth, Trends and Forecasts (2019 2028)\n\n
| \n\n |
Report Overview The South Korea anti-aging therapeutics market size stood at around USD xx billion in 2019 and is pro... Read More
-
Dec 2022
-
Pages: 200
- Get FREE Sample
South Korea Type 2 Diabetes Market: Segmented By Drug Class (Dipeptidyl Peptidase-4 [DPP-4] Inhibitors, Alpha-glucosidase Inhibitors, Biguanides, Glucagon-Like Peptide-1 [GLP-1] Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors [SGLT2], Sulfonylureas, Other [Thiazolidinedione, Meglitinides, Glitazones]) and By Application (Glycaemic Control, Cardiovascular Safety, Hypoglycaemic Avoidance and Others) - Growth, Trends and Forecasts (2019 2028)
Report Overview The South Korea type 2 diabetes market size stood at around USD 460 million in 2019 and is projected ... Read More
-
Dec 2022
-
Pages: 200
- Get FREE Sample
South Korea Glucagon Like Peptide-1 (GLP-1) Receptor Agonist Market: Segmented By Drugs (Exenatide, Liraglutide, Lixisenatide, Albiglutide, Dulaglutide and Others) - Growth, Trends and Forecasts (2019 2028)
Report Overview The South Korea glucagon like peptide-1 (GLP-1) receptor agonist market size stood at around USD xx b... Read More
-
Dec 2022
-
Pages: 200
- Get FREE Sample
South Korea Sodium Glucose Co-Transporter 2 (SGLT 2) Inhibitor Market: Segmented By Drug Class (Canagliflozin, Empagliflozin, Dapagliflozin, Ipragliflozin and Others) - Growth, Trends and Forecasts (2019 2028)
Report Overview The South Korea sodium glucose co-transporter 2 (SGLT 2) inhibitor market size stood at around USD 90... Read More
-
Dec 2022
-
Pages: 200
- Get FREE Sample
South Korea Dipeptide Peptidase 4 (DPP-4) Inhibitors Market: Segmented By Drugs (Sitagliptin, Saxagliptin, Linagliptin, Alogliptin, Vildagliptin and Others) - Growth, Trends and Forecasts (2019 2028)
Report Overview The South Korea dipeptide peptidase 4 (DPP-4) inhibitors market size stood at around USD 415.5 millio... Read More
-
Dec 2022
-
Pages: 200
- Get FREE Sample
South Korea Peptic Ulcer Market: Segmented By Drug Class (Proton Pump Inhibitors [PPIs], Antihistamines, H2 Antagonists, Antacids, Antibiotics And Others) and By Clinical Application (Gastric Ulcers, Duodenal Ulcer, Oesophageal Ulcer) - Growth, Trends and Forecasts (2019 2028)
Report Overview The South Korea peptic ulcer market size stood at around USD 721.7 million in 2019 and is projected t... Read More
-
Dec 2022
-
Pages: 200
- Get FREE Sample
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
- Forecasting
- Benchmarking and Competitive Intelligence
- Technology Assessment
- End-User Analysis
- Partner and Pricing Analysis
- Market Assessment and Entry
- New Product Development
